Zampieri, S., Bembi, B., Rosso, N., Filocamo, M., & Dardis, A. (2011). Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking. Springer Berlin Heidelberg.
Chicago ZitierstilZampieri, Stefania, Bruno Bembi, Natalia Rosso, Mirella Filocamo, und Andrea Dardis. Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations With MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking. Springer Berlin Heidelberg, 2011.
MLA ZitierstilZampieri, Stefania, et al. Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations With MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking. Springer Berlin Heidelberg, 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.